Drug Development for Neglected Diseases
From PHM Oz
(Difference between revisions)
| Line 1: | Line 1: | ||
<center>''This page is under construction, please be patient as we develop it further''</center> | <center>''This page is under construction, please be patient as we develop it further''</center> | ||
| + | orphan diseases | ||
| + | |||
| + | DINDI | ||
| + | |||
| + | under-investment in the development of drugs for neglected diseases | ||
| + | |||
| + | reference to WHO Commission | ||
[[Intellectual Property and Pharmaceuticals|Back to IP home]] | [[Intellectual Property and Pharmaceuticals|Back to IP home]] | ||
Revision as of 04:05, 16 June 2007
orphan diseases
DINDI
under-investment in the development of drugs for neglected diseases
reference to WHO Commission
